Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Cureus ; 14(5): e25319, 2022 May.
Article in English | MEDLINE | ID: covidwho-1897136

ABSTRACT

INTRODUCTION:  Pulmonary hypertension (PH) is a threatening condition, and it is far more common than previously assumed, especially after the COVID pandemic. Its outcome is not good; if detected late, and can lead to right ventricular failure, which can be fatal. Our goal was to evaluate CT signs of PH, correlate them with echocardiography, and identify the cut-off values of these signs in our population. METHOD:  In this study, 160 patients having both CT and echocardiography with a maximum gap of one month were assessed from June to November 2021. The association between CT signs and echocardiography to diagnose PH was investigated. The Pearson and Spearman correlation and area under receiver operating curve (AUROC) tests were performed in the analysis. Receiver operating characteristic curve analysis was also used to assess CT's diagnostic capability and cut-off values. RESULT:  The correlation between main pulmonary artery (MPA) diameter and main pulmonary artery to aorta ratio (MPA/AO) with mean pulmonary artery pressure (mPAP) was weak but statistically significant (r = 0.316 and r = 0.321, p<0.001). However, there was a very weak correlation between the right and left pulmonary artery and mPAP with correlation coefficients (r) of 0.155 and 0.138, respectively. For the first time in our population, we measured the cut-off values of MPA and MPA/AO ratios for PH which were 26 and 0.88 mm, respectively. CONCLUSIONS:  The CT signs of PH correlate with echocardiography; however, should not be used solely; the cut-off values should be used according to race and population.

3.
Indian Heart J ; 74(1): 51-55, 2022.
Article in English | MEDLINE | ID: covidwho-1587679

ABSTRACT

BACKGROUND: Covid-19 is multi-system viral infection caused by SARS-CoV-2 virus. Apart from having acute severe respiratory illness causing high mortality, the disease also has a variety of cardiovascular manifestations contributing to morbidity as well as mortality. Cardiac dysfunction and myocarditis are well established complications of Covid-19 as evident in multiple studies after the Covid-19 pandemic. However it is not sufficiently studied in Indian patients either by Echocardiography or by any other imaging modalities like cardiac magnetic resonance imaging (MRI). METHODOLOGY: In this study, we analysed the severity of Left ventricular(LV) dysfunction in Covid-19 survivors. A total of 100 consecutive patients of Covid-19 after one month of discharge who had no underlying cardiovascular diseases underwent echocardiography and global longitudinal strain (GLS) imaging. This study cohort included patients with mild 42 (42%),moderate 46(46%) and severe 12(12%) Covid-19 disease as defined by computerised tomography (CT) severity score. RESULT: We observed that total 36(36%) patients had reduced ejection fraction(EF) which included 11 patients having EF <40% and remaining 25(25%) having EF 40-50% (p<0.002). Also 22 (22%) patients had abnormal global longitudinal strain (GLS) values with normal ejection fraction which is suggestive of subclinical myocarditis. We observed LV dysfunction in 7(19.5%) patients who had severe Covid-19 while mild to moderate LV dysfunction observed in 29(80.5%) non critical patients. CONCLUSION: In conclusion our study demonstrates that myocardial dysfunction is common in covid-19 regardless of disease severity. 2D-echocardiography with GLS is likely to detect early LV dysfunction among these patients.


Subject(s)
COVID-19 , Ventricular Dysfunction, Left , Humans , Pandemics , SARS-CoV-2 , Stroke Volume , Survivors , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/epidemiology , Ventricular Function, Left
4.
Echocardiography ; 37(10): 1673-1677, 2020 10.
Article in English | MEDLINE | ID: covidwho-799148

ABSTRACT

We report the case of a healthy 35-year-old woman who had experienced a flu-like syndrome during the week before childbirth and heart failure symptoms 10 days before the current hospitalization and presented to our emergency department with clinical signs of congestive heart failure, echocardiographic evidence of a severely dilated and hypokinetic heart, laboratory evidence of SARS-CoV-2 disease, and radiologic findings consistent with both virus-related pneumonia and heart failure. Early cardiac magnetic resonance was crucial for the diagnosis of postpartum cardiomyopathy and for the exclusion of virus-related myocarditis, allowing us to decide on a prudent and supportive clinical approach.


Subject(s)
Betacoronavirus , Cardiomyopathies/diagnosis , Coronavirus Infections/complications , Electrocardiography/methods , Myocarditis/diagnosis , Peripartum Period , Pneumonia, Viral/complications , Pregnancy Complications, Cardiovascular/diagnosis , Acute Disease , Adult , COVID-19 , Cardiomyopathies/epidemiology , Comorbidity , Coronavirus Infections/epidemiology , Diagnosis, Differential , Echocardiography , Female , Humans , Magnetic Resonance Imaging, Cine/methods , Myocarditis/epidemiology , Pandemics , Pneumonia, Viral/epidemiology , Pregnancy , SARS-CoV-2 , Tomography, X-Ray Computed
5.
Echocardiography ; 37(8): 1296-1299, 2020 08.
Article in English | MEDLINE | ID: covidwho-690498

ABSTRACT

We present a late presentation of saddle pulmonary embolism and thrombus-in-transit straddle the patent foramen on patient who successfully recovered from severe acute respiratory syndrome coronavirus-2 (COVID-19) pneumonia. Seven days postdischarge (ie, 28 days after initial COVID-19 symptom onset), she was readmitted to hospital for severe dyspnea. Computer tomography angiogram and echocardiography confirmed the diagnosis. Severe pro-inflammatory and pro-thrombotic states with endothelial involvement have been reported associated with severe COVID-19 infection. However, the duration of hypercoagulable state has not yet known. This case highlights the risk of thromboembolic phenomena for prolonged periods of times after recovering from COVID-19 pneumonia.


Subject(s)
Anticoagulants/therapeutic use , COVID-19/complications , Echocardiography/methods , Foramen Ovale, Patent/diagnostic imaging , Pulmonary Embolism/diagnostic imaging , Thrombosis/diagnostic imaging , Aged , Computed Tomography Angiography/methods , Dyspnea/etiology , Enoxaparin/analogs & derivatives , Enoxaparin/therapeutic use , Female , Heparin/therapeutic use , Humans , Patient Readmission , Pulmonary Embolism/drug therapy , Pulmonary Embolism/etiology , Thrombosis/drug therapy , Thrombosis/etiology
SELECTION OF CITATIONS
SEARCH DETAIL